Hydroxyapatite Market

Berkeley Advanced Biomaterials will lead hydroxyapatite sales through 2035 with an estimated 18-22% company share. Medical grade hydroxyapatite remains the leading grade segment. The market was valued at USD 583.1 million in 2025 and is projected to reach USD 1.2 billion by 2035 as dental applications command a significant share.